HR3200 Page 1193

You might also like

Download as pdf or txt
Download as pdf or txt
You are on page 1of 2

1193 1 2 3 4 5 6 7 8 9 (1) IN

GENERAL.Section

519 of the Federal

Food, Drug, and Cosmetic Act (21 U.S.C. 360i) is amended (A) by redesignating subsection (g) as subsection (h); and (B) by inserting after subsection (f) the following: National Medical Device Registry (g)(1) The Secretary shall establish a national med-

10 ical device registry (in this subsection referred to as the reg11 istry) to facilitate analysis of postmarket safety and out12 comes data on each device that 13 14 15 16 17 18 (A) is or has been used in or on a patient; and (B) is (i) a class III device; or (ii) a class II device that is implantable, life-supporting, or life-sustaining. (2) In developing the registry, the Secretary shall, in

19 consultation with the Commissioner of Food and Drugs, the 20 Administrator of the Centers for Medicare & Medicaid Serv21 ices, the head of the Office of the National Coordinator for 22 Health Information Technology, and the Secretary of Vet23 erans Affairs, determine the best methods for
bajohnson on DSK2BSOYB1PROD with BILLS

24 25

(A) including in the registry, in a manner consistent with subsection (f), appropriate information to

HR 3200 RH
VerDate Nov 24 2008 03:16 Oct 15, 2009 Jkt 089200 PO 00000 Frm 01193 Fmt 6652 Sfmt 6203 E:\BILLS\H3200.RH H3200

1194 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23
bajohnson on DSK2BSOYB1PROD with BILLS

identify each device described in paragraph (1) by type, model, and serial number or other unique identifier; (B) validating methods for analyzing patient safety and outcomes data from multiple sources and for linking such data with the information included in the registry as described in subparagraph (A), including, to the extent feasible, use of (i) data provided to the Secretary under other provisions of this chapter; and (ii) information from public and private sources identified under paragraph (3); (C) integrating the activities described in this subsection with (i) activities under paragraph (3) of section 505(k) (relating to active postmarket risk identification); (ii) activities under paragraph (4) of section 505(k) (relating to advanced analysis of drug safety data); and (iii) other postmarket device surveillance activities of the Secretary authorized by this chapter; and (D) providing public access to the data and analysis collected or developed through the registry in

24 25

HR 3200 RH
VerDate Nov 24 2008 03:16 Oct 15, 2009 Jkt 089200 PO 00000 Frm 01194 Fmt 6652 Sfmt 6203 E:\BILLS\H3200.RH H3200

You might also like